KLRS
Kalaris Therapeutics
KLRS
KLRS
84 hedge funds and large institutions have $184M invested in Kalaris Therapeutics in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
44% less capital invested
Capital invested by funds: $329M → $184M (-$145M)
Holders
84
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$9.72M | |
| 2 | +$3.75M | |
| 3 | +$3.15M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$1.12M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$860K |
Top Sellers
| 1 | -$4.37M | |
| 2 | -$3.38M | |
| 3 | -$1.18M | |
| 4 |
Rafferty Asset Management
New York
|
-$816K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$778K |